TTRX Turn Therapeutics, Inc.

NASDAQ
$12.49

Turn Therapeutics, Inc. (TTRX) is expected to report earnings on November 11, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +21.0% since its last earnings release on August 12, 2026.

Turn Therapeutics Reported Earnings
Wednesday, August 12, 2026 · 4:30 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:30 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.01

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Turn Therapeutics, Inc.

Turn Therapeutics is a clinical-stage biotechnology company developing next-generation dermatology, wound and anti-infective therapies. Turn Therapeutics is based in WESTLAKE VILLAGE, Calif.

Charts powered in part by Lightweight Charts™ by TradingView.